Via posts strong Q3 results with government demand, major wins, viral adoption, record customers and NRR above 120% driving ...

As of Friday, November 28, ImmunityBio, Inc.’s IBRX share price has surged by 11.03%, which has investors questioning if this is right time to sell.

As of Friday, November 28, Outlook Therapeutics, Inc.’s OTLK share price has surged by 6.55%, which has investors questioning if this is right time to sell.

Galicia's weak Q3 loss from margin and HSBC costs with scale intact, deposits and credit up, shares up on macro gains. Learn ...

Netflix finds itself at a pivotal moment as its shares stabilize near $106 after the company's recent 10-for-1 stock split. This apparent calm, however, mask ...

The announcement from Credo Technology Group is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter. It's worth no ...

Betting markets misprice games more often than you think. Discover the data cues and bookmaker errors to spot betting ...

The report of sagging household confidence aligns with a University of Michigan survey that found inflation and pressure on personal incomes pushed down consumer sentiment this month.

Solana ETFs posted 19 consecutive days of inflows totaling $476M, defying a crypto crash. Bitwise BSOL leads with $424M.

The upcoming CBA negotiations could lead small-market MLB teams to spend more aggressively in free agency. From Pittsburgh to ...

Is there a more promising option? It appears that its counterpart, NVIDIA, offers you more. NVIDIA (NASDAQ: NVDA) stock ...

But does the increase from yesterday indicate that this is a good time to buy, or are we merely trying to catch a falling ...